Cardiac Disease in Pregnancy

Patrick S. Ramsey; Kirk D. Ramin; Susan M. Ramin

doi:10.1055/s-2001-16991

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2001; 18(5): 245-266
DOI: 10.1055/s-2001-16991

ORIGINAL ARTICLES

Cardiac Disease in Pregnancy

Patrick S. Ramsey¹ , Kirk D. Ramin² , Susan M. Ramin³

¹Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
²Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Mayo Medical Center, Rochester, Minnesota
³Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas-Houston Medical School, Houston Texas

Abstract

ABSTRACT

Cardiovascular adaptations of pregnancy are generally well tolerated in the healthy gravida; however, these changes can place undue stress on women with underlying cardiovascular disease and can result in increased risk for morbidity and mortality. In this article, we will review issues related to preconceptional counseling, cardiovascular adaptations of pregnancy, and the prognosis and management of the gravida with cardiac disease in pregnancy.

KEYWORD

Cardiac disease - pregnancy - preconceptional

Volltext

Referenzen

REFERENCES

1 McFaul P B, Dornan J C, Lamki H, Boyle D. Pregnancy complicated by maternal heart disease: a review of 519 women. Br J Obstet Gynaecol . 1988; 95 861-867
2 Wooley C F, Sparks E H. Congenital heart disease, heritable cardiovascular disease and pregnancy. Progr Cardiovasc Dis . 1992; 35 41-60
3 Metcalfe J, McAnulty J H, Ueland K. Cardiovascular physiology. Clin Obstet Gynecol . 1981; 24 693-710
4 Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Progr Cardiovasc Dis . 1974; 16 363-374
5 Clark S L, Cotton D B, Hankins G DV, Phelan J P. Cardiac disease. In: Critical Care Obstetrics. 3rd ed. Malden, MA: Blackwell Science 1997: 290-313
6 Greiss F C, Anderson S G. Effect of ovarian hormones on the uterine vasculature bed. Am J Obstet Gynecol . 1970; 23 765-768
7 Bryant E E, Douglas B H, Ashburn A D. Circulatory changes following prolactin administration. Am J Obstet Gynecol . 1973; 115 53-57
8 Gerber J G, Payne N A, Murphy R C, Nies A S. Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest . 1981; 67 632-636
9 Soares De Maura R. Effect of prostacyclin on the perfusion pressure and the vasoconstrictor response of angiotensin II in the human isolated foetal placental circulation. Br J Clin Pharmacol . 1987; 23 765-768
10 Carruth J E, Mivis S B, Brogan D R, Wenger N K. The electrocardiogram in normal pregnancy. Am Heart J . 1981; 102 1075-1078
11 Upshaw C B. A study of maternal electrocardiograms recorded during labor and delivery. Am J Obstet Gynecol . 1970; 107 17-27
12 Kerr M G. Cardiovascular dynamics in pregnancy and labor. Br Med Bull . 1968; 24 19-24
13 Robson S C, Dunlop W, Boys R J, Hunter S. Cardiac output during labor. Br Med J . 1987; 295 1169-1172
14 Kjeldsen J. Hemodynamic investigations during labor and delivery. Acta Obstet Gynecol Scand Suppl . 1979; 89 1-252
15 Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels 8th ed. Boston: Little Brown; 1979
16 Nora J J, Nora A H. Genetics and Counseling in Cardiovascular Disease. Springfield, IL: Charles Thomas; 1978
17 Nora J J, Nora A H. Maternal transmission of congenital heart disease: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol . 1987; 59 459-463
18 Pilu G, Baccarani G, Perolo A, Picchio F M, Bovicelli L. Prenatal diagnosis of congenital heart disease. In: Fleischer AC, Manning FA, Jeanty P, Romero R, eds. Sonography in Obstetrics and Gynecology: Principles and Practice 5th ed. Stamford, CT: Appleton & Lange 1996: 149-172
19 American College of Obstetricians and Gynecologists. Cardiac disease in pregnancy. ACOG Technical Bull . 1992; 168 1-8
20 Clark S L. Labor and delivery in the patient with structural cardiac disease. Clin Perinatol . 1986; 13 695-703
21 Szekely P, Turner R, Snaith L. Pregnancy and the changing pattern of rheumatic heart disease. Br Heart J . 1973; 35 1293-1303
22 Romero R, Pilu G, Jeanty P, Ghidini A, Hobbins. Approaches to the Examination of the Fetal Heart. In: Prenatal Diagnosis of Congenital Anomalies. Norwalk, CT: Appleton & Lange; 1988
23 Paladini D, Calabro R, Palmieri S, D'Andrea T. Prenatal diagnosis of congenital heart disease and fetal karyotyping. Obstet Gynecol . 1993; 81 679-682
24 Copel J A, Cullen M, Green J J, Mahoney M J, Hobbins J C, Kleinman C S. The frequency of aneuploidy in prenatally diagnosed congenital heart disease: an indication for fetal karyotyping. Am J Obstet Gynecol . 1988; 158 409-413
25 Whittemore R, Hobbins J C, Eagle M A. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol . 1982; 50 641-651
26 Mortenson J D, Ellsworth H S. Pregnancy before and after surgical correction of left-to-right cardiovascular shunts. Obstet Gynecol . 1967; 29 241-243
27 Clark S L, Phelan J P, Greenspoon J, Aldahl D, Horenstein J. Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol . 1985; 152 984-988
28 Szekely P, Julian D G. Heart disease and pregnancy. Curr Probl Cardiol . 1979; 4 1-74
29 Ducey J P, Ellsworth S M. The hemodynamic effects of severe mitral stenosis and pulmonary hypertension during labor and delivery. Intensive Care Med . 1989; 15 192-195
30 Markiewicz W, Stoner J, London E, Hunt S A, Popp R L. Mitral valve prolapse in one hundred previously healthy young females. Circulation . 1976; 53 464-473
31 Tank L CH, Chan S YW, Wong V CM. Pregnancy in patients with mitral valve prolapse. Int J Gynecol Obstet . 1985; 23 217-221
32 Haas J M. The effect of pregnancy on the midsystolic click and murmur of the prolapsing posterior leaflet of the mitral valve. Am Heart J . 1976; 92 407-408
33 Rayburn W F, Fontana M E. Mitral valve prolapse and pregnancy. Am J Obstet Gynecol . 1981; 141 9-11
34 Dajani A S, Taubert K A, Wilson W. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA . 1997; 277 1794-1801
35 Barash P G, Hobbins J C, Hook R. Management of coarctation of the aorta during pregnancy. J Thorac Cardiovasc Surg . 1975; 69 781-784
36 Deal K, Wooley C F. Coarctation of the aorta and pregnancy. Ann Intern Med . 1973; 78 706-710
37 Ramin S M, Maberry M C, Gilstrap L C. Congenital heart disease. Clin Obstet Gynecol . 1989; 32 41-47
38 Mendelson C L. Pregnancy and coarctation of the aorta. Am J Obstet Gynecol . 1940; 39 1014-1021
39 Goodwin J F. Pregnancy and coarctation of the aorta. Clin Obstet Gynecol . 1961; 4 645
40 Homans D C. Peripartum cardiomyopathy. N Engl J Med . 1985; 312 1432-1436
41 Veille J C. Peripartum cardiomyopathies: a review. Am J Obstet Gynecol . 1984; 148 805-818
42 Pearson G D, Veille J C, Hsia J. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop Recommendations and Review. JAMA . 2000; 283 1183-1188
43 Demakis J G, Rahimtoala S H, Sutton. Natural course of peripartum cardiomyopathy. Circulation . 1971; 44 1053-1061
44 Demakis J G, Rahimtoala S H. Peripartum cardiomyopathy. Circulation . 1971; 44 964-968
45 Walsh J J, Burch G E. Postpartal heart disease. Arch Intern Med . 1961; 108 817-822
46 Cunningham F G, Pritchard J A, Hankins G VD, Anderson P L, Lucas M J, Armstrong K F. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events?. Obstet Gynecol . 1986; 67 157-167
47 Lang R M, Lampert M B, Poppas A, Hameed A, Elkayam U. Peripartal cardiomyopathy. In: Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy 3rd ed. New York: Wiley-Liss 1998: 87-100
48 Melvin K R, Richardson P J, Olsen E G, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med . 1982; 307 731-734
49 Felker G M, Thompson R E, Hare J M. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med . 2000; 342 1077-1084
50 Sutton M S, Cole P, Plappert M, Saltzman D, Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J . 1991; 121 1776-1778
51 Lampert M, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang R M. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol . 1997; 176 189-195
52 Witlin A G, Mabie W C, Sibai B M. Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gyencol . 1997; 176 182-188
53 Easterling T R, Chadwick H S, Otto C M, Benedetti T J. Aortic stenosis in pregnancy. Obstet Gynecol . 1988; 72 113-118
54 Arias F, Pinedo J. Aortic stenosis and pregnancy. J Reprod Med . 1978; 20 229-232
55 Angel J L, Chapman C, Knappel R A, Morales W J, Sims C J. Percutaneous balloon aortic valvuloplasty in pregnancy. Obstet Gynecol . 1988; 72 438-440
56 Sullivan J M, Ramanathan K B. Management of medical problems in pregnancy: severe cardiac disease. N Engl J Med . 1985; 313 304-309
57 Landon M. Cardiac and pulmonary disease. In: Gabbe SG, Niebyl JR, Simpson JL Obstetrics: Normal & Problem Pregnancies. 3rd ed. New York: Churchill Livingston 1996: 997-1013
58 Neilson G, Galea E G, Blunt A. Congenital heart disease and pregnancy. Med J Aust . 1970; 1 1086-1088
58a Mendelson C L. Congenital heart disease. In: Cardiac Disease in Pregnancy: Medical Care, Cardiovascular Surgery, and Obstetric Management as Related to Maternal and Fetal Welfare Philadelphia: FA Davis 1960: 122-175
59 Schaefer G, Arditi L I, Solomon H A, Ringland J E. Congenital heart disease and pregnancy. Clin Obstet Gynecol . 1968; 11 1048-1063
60 Bjornsson J, Edwards W D. Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc . 1985; 60 16-25
61 Fuster V, Steele P M, Edwards W D, Gersh B J, McGoon M D, Frye R L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation . 1984; 70 580-587
62 Weiss B M, Zemp L, Seifert B, Hess O. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Casdiol . 1998; 31 1650-1657
63 Smedstad K G, Cramb R, Morison D H. Pulmonary hypertension and pregnancy: a series of eight cases. Can J Anaesth . 1994; 41 502-512
64 Tahir H. Pulmonary hypertension, cardiac disease and pregnancy. Int J Gynecol Obstet . 1995; 51 109-113
65 Dankins K D, Burke C M, Billingham M E, Jamieson S W. Primary pulmonary hypertension and pregnancy. Chest . 1986; 89 383-388
66 Kleiger R E, Boxer M, Ingham R E, Harrison D C. Pulmonary hypertension in patients using oral contraceptives: a report of six cases. Chest . 1979; 69 143-147
67 Rich S, Dantzker D R, Ayres S M. Primary pulmonary hypertension: a national prospective study. Ann Intern Med . 1987; 107 216-223
68 Sinnenberg Jr J R. Pulmonary hypertension in pregnancy. South Med J . 1980; 73 1529-1531
69 Midwall J, Jaffin H, Herman M V, Kupersmith J. Shunt flow and pulmonary hemodynamics during labor and delivery in the Eisenmenger's syndrome. Am J Cardiol . 1978; 42 299-303
70 McCaffrey R M, Dunn L J. Primary pulmonary hypertension in pregnancy. Obstet Gynecol Surv . 1964; 19 567-591
71 Nelson D M, Main E, Crafford W, Ahumado G G. Peripartum heart failure due to primary pulmonary hypertension. Obstet Gynecol . 1983; 62 595-635
72 Rich S, Kaufmann E, Levy P S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med . 1992; 327 76-81
73 Rubin L J, Mendoza J, Hood M. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin. Ann Int Med . 1990; 112 485-491
74 Barst R J, Rubin L J, Long W A, for the Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (Prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med . 1996; 334 296-301
75 Hoeper M M, Schwarze M, Ehlerding S. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med . 2000; 342 1866-1870
76 Easterling T R, Ralph D D, Schmucker B C. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol . 1999; 93 494-498
77 Lust K M, Boots R J, Dooris M, Wilson J. Management of labor in Eisenmenger syndrome with inhaled nitric oxide. Am J Obstet Gynecol . 1999; 181 419-423
78 Goodwin T M, Gherman R B, Hameed A, Elkayam U. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol . 1999; 180 64-67
79 Gleicher N, Midwell J, Hochberger D, Jaffin H. Eisenmenger's syndrome and pregnancy. Obstet Gynecol Surv . 1979; 34 721-741
80 Lieber S, Dewilde P H, Huyghens L, Traey E, Gepts E. Eisenmenger's syndrome and pregnancy. Acta Cardiol . 1986; 40 421-424
81 Yentis S M, Steer P J, Plaat F. Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990's. Br J Obstet Gynaecol . 1988; 105 921-922
82 Pitts J A, Crosby W M, Basta L L. Eisenmenger's syndrome in pregnancy; does heparin prophylaxis improve the maternal mortality rate?. Am Heart J . 1977; 93 321-326
83 Patton D E, Lee W, Cotton D B. Cyanotic maternal heart disease in pregnancy. Obstet Gynecol Surv . 1990; 45 594-600
84 Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease: outcome of mother and fetus. Circulation . 1994; 89 2673-2676
85 Shime J, Mocarski E JM, Hastings D, Webb G D, McLaughin P R. Congenital heart disease in pregnancy: short and long-term implications. Am J Obstet Gynecol . 1987; 156 313-322
86 Mabie W C, Freire C M. Sudden chest pain and cardiac emergencies in the obstetric patient. Obstet Gynecol Clin North Am . 1995; 22 19-37
87 Raymond R, Lynch J, Underwood D, Leatherman J, Razavi M. Myocardial infarction and normal coronary arteriography: a 10 year clinical and risk analysis of 74 patients. J Am Coll Cardiol . 1988; 11 471-477
88 Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med . 1996; 125 751-762
89 Lee T H, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med . 2000; 342 1187-1195
90 Shivvers S A, Wians Jr H F, Keffer J H, Ramin S M. Maternal cardiac troponin I levels during normal labor and delivery. Am J Obstet Gynecol . 1999; 180 122
91 Hankins G DV, Wendel Jr D G, Leveno K J, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet Gynecol . 1985; 65 139-146
92 Brown C EL, Wendel G D. Cardiac arrythmias during pregnancy. Clin Obstet Gynecol . 1989; 32 89-102
93 Schroeder J S, Harrison D C. Repeated cardioversion during pregnancy: treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol . 1971; 27 445-446
94 Rotmensch H H, Rotmensch S, Elkayam U. Management of cardiac dysrhythmia during pregnancy: current concepts. Drugs . 1987; 33 623-633
95 Jaffe R, Gruber A, Fejgin M. Pregnancy with an artificial pacemaker. Obstet Gynecol Surv . 1987; 42 137-139
96 Sbarouni E, Oakley C M. Outcome of pregnancy in women with valve prostheses. Br Heart J . 1994; 71 196-201
97 Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG . 2000; 107 245-253
98 Ginsberg J S, Kowalchuk G, Hirsh J. Heparin therapy during pregnancy: risks to the fetus and mother. Arch Intern Med . 1989; 149 2233-2236
99 Ramin S M, Ramin K D, Gilstrap L C. Anticoagulation and thrombolytics during pregnancy. Semin Perinatol . 1997; 21 149-153
100 Hall J G, Pauli R M, Wilson K M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med . 1980; 68 122-140
101 Stevenson R E, Burton M, Ferlauto G J, Taylor H A. Hazards of oral anticoagulants during pregnancy. JAMA . 1980; 243 1549-1551
102 Oakley C, Doherty P. Pregnancy in patients after valve replacement. Br Heart J . 1976; 38 1140-1148
103 Anutes M J, Myer I G, Santos L P. Thrombosis of mitral valve prosthesis in pregnancy: management by simultaneous cesarean section and mitral valve replacement-case report. Br J Obstet Gynaecol . 1984; 91 716-718
104 Salazar E, Zajarias A, Gutiarraz N, Iturbe I. The problem of cardiac valve prostheses: anticoagulants and pregnancy. Circulation . 1984; 70 169-177
105 Iturbe-Alessio I, Fonseca M DC, Mutchinick O, Santos M A, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial valves. N Engl J Med . 1986; 27 1390-1393
106 Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve protheses. J Am Coll Cardiol . 1996; 27 1698-1703
107 Dalen E, Hirsh J. American College of Chest Physicians and the National Heart, Lung, and Blood Institute National Conference on Antithrombotic Therapy. Chest . 1986; 89 1S-106S
108 Bortolloti U, Milano A, Mazzucco A. Pregnancy in patients with a porcine valve prosthesis. Am J Cardiol . 1982; 50 1051-1054
109 Cotrufo M, De Luca S L T, Calabro R. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg . 1991; 5 500-505
110 Dashe J S, Ramin K D, Ramin S M. Pregnancy following cardiac transplantation. Prim Care Update Ob/Gyn . 1998; 5 257-262
111 Scott J R, Wagoner L E, Olsen S L, Taylor D O, Renlund D G. Pregnancy in heart transplant recipients: management and outcome. Obstet Gynecol . 1993; 82 324-327
112 Kim K M, Sukhani R, Slogoff S, Tomich P G. Central hemodynamic changes associated with pregnancy in a long-term cardiac transplant recipient. Am J Obstet Gynecol . 1996; 174 1651-1653